Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stone Clinical Laboratories provided advanced molecular diagnostics, laboratory testing, and toxicology supporting preventative care, infectious disease detection, cancer screening, and pharmacogenetics in commercial lab operations across the Southeast U.S.; it was acquired by Fibronostics to expand capabilities in non-invasive metabolic and liver disease diagnostics, notably supporting clinical validation and digital biomarker platforms in MASH/MASLD[2][1][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stone Clinical Laboratories.